UK Clinical Vaccine Network Conference 2022

Bringing together and showcasing the work of the UK clinical vaccine community, to facilitate co-operation and collaborate on future challenges.

Register now

It is with great excitement that we can announce this year’s Clinical Vaccine Network Conference will be held in person at the Royal College of Physicians, London.

Hosted on the 30th June, this event will cover a wide spectrum of issues in vaccine development, presentations on the latest research, and the future of vaccines.

Whilst this conference will be made available to join virtually we thoroughly recommend attending in person to not miss out on this excellent networking opportunity. There will be an array of UK healthcare professionals, and other relevant decision makers who have a specific interest in vaccine intervention in the patient pathway.

Please share the flyer for the event available here with your colleagues.

If you have any queries, or would like to enquire about sponsorship of this event, please contact: hayley@pagemedical.co.uk.

@CVN_UK

To view the recordings from the online UK Clinical Vaccine Network Conference held in 2020 please click here

Prof Mary Slack

Professor Slack is an Independent Consultant Medical Microbiologist. She was formerly employed by Public Health England (PHE) as Consultant Medical Microbiologist and Head of the Haemophilus Reference Unit in the Respiratory & Vaccine Preventable Bacteria Reference Unit, Colindale, London, United Kingdom. She coordinated the laboratory aspects of enhanced population-based surveillance on invasive H. influenzae and pneumococcal disease in England and Wales. From 1975 to 2003 she was the University Lecturer (Honorary Consultant) in Bacteriology at the University of Oxford, being responsible for clinical microbiology teaching to Oxford Clinical Medical Students.

She was formerly Head of the WHO Collaborating Centre for Haemophilus influenzae and Head of the Global Reference Laboratory for H. influenzae in the WHO Global Vaccine-Preventable Invasive Bacterial Disease (VP-IBD) Surveillance Network. She has worked extensively in developing countries- assisting WHO, PATH, IVI, Hib Initiative and PneumoADIP by providing technical support, advice and training for sentinel site surveillance of paediatric bacterial meningitis, pneumonia and sepsis. Her principal research interests include the epidemiology of invasive haemophilus and pneumococcal infections and the impact of Hib and pneumococcal conjugate vaccines. Her findings in these areas have been widely published and presented at national and international meetings.

Top